Palantir (NASDAQ: PLTR) stock climbed 5.9% after the data analytics and defense software group posted its biggest quarterly ...

Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q2 CY2025, with sales up 10.3% year ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Wall Street roared back to life on Monday, as it posted its strongest gains in more than two months after recouping losses ...

Pfizer (PFE) increased its 2025 profit outlook by 10 cents a share to a range of $2.90 a share to $3.10 a share, citing continued cost cuts, a lower tax rate and "confidence" that strength seen in the ...

The biggest deterrent to bull market returns has been the "watershed destruction of U.S. confidence," says Paulsen. Since 1960, when U.S. consumer confidence has risen monthly, the S&P 500 average ...

U.S. stocks appear set for a positive opening on Tuesday as investors turn their focus to earnings, helping the S&P 500 snap ...

Pfizer (NYSE:PFE) shares traded higher in the premarket on Tuesday after the New York-based pharma giant reported better-than ...

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Pfizer's second-quarter 2025 results exceeded expectations with a 10% revenue growth and an adjusted EPS of $0.78.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

The New York-based company said it had profit of 51 cents per share. Earnings, adjusted for one-time gains and costs, were 78 cents per share. The results beat Wall Street expectations.